Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cormedix (CRMD)
NASDAQ:CRMD
Cormedix (CRMD) Stock Price & Analysis
931 Followers
CRMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.71 - $6.09
Previous Close$3.7
Volume530.02K
Average Volume (3M)569.65K
Market Cap
$202.80M
Enterprise ValueN/A
Total Cash (Recent Filing)$52.49M
Total Debt (Recent Filing)$736.86K
Price to Earnings (P/E)-4.3
Beta1.30
Next Earnings
Nov 09, 2023EPS Estimate
-$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.85
Shares Outstanding54,805,376
10 Day Avg. Volume535,323
30 Day Avg. Volume569,654
Standard Deviation0.25
R-Squared0.16
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)4.10
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio8594.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$14.33Price Target Upside287.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Cormedix News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRMD FAQ
What was Cormedix’s price range in the past 12 months?
Cormedix lowest stock price was $2.71 and its highest was $6.09 in the past 12 months.
What is Cormedix’s market cap?
Currently, no data Available
When is Cormedix’s upcoming earnings report date?
Cormedix’s upcoming earnings report date is Nov 09, 2023 which is in 40 days.
How were Cormedix’s earnings last quarter?
Cormedix released its earnings results on Aug 08, 2023. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.239 by -$0.011.
Is Cormedix overvalued?
According to Wall Street analysts Cormedix’s price is currently Undervalued.
Does Cormedix pay dividends?
Cormedix does not currently pay dividends.
What is Cormedix’s EPS estimate?
Cormedix’s EPS estimate is -$0.24.
How many shares outstanding does Cormedix have?
Cormedix has 54,812,042 shares outstanding.
What happened to Cormedix’s price movement after its last earnings report?
Cormedix reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.239. Following the earnings report the stock price went up 7.805%.
Which hedge fund is a major shareholder of Cormedix?
Among the largest hedge funds holding Cormedix’s share is Elliott Investment Management LP. It holds Cormedix’s shares valued at 6M.
---
Cormedix Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.33 (287.30% Upside)
$14.33 (287.30% Upside)
Blogger Sentiment
Bullish
CRMD Sentiment 100%
Sector Average 68%
Sector Average 68%
Insider Transactions
Bought Shares
Worth $37.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.6%
Last 30 Days ▼ 9.0%
Last 30 Days ▼ 9.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
31.20%
12-Months-Change
Fundamentals
Return on Equity
-66.62%
Trailing 12-Months
Asset Growth
-15.82%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cormedix
CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.
---
Top 5 ETFs holding CRMD
Vanguard Total Stock Market ETF
$6.71M
iShares Russell 3000 ETF
$81.98K
Vanguard Russell 3000 ETF
$11.34K
Dimensional US Sustainability Core 1 ETF
$59.04
Up to five ETFs with an Outperform Smart Score that hold CRMD. The ETFs are listed according to market value of CRMD within the ETF
---